Sagimet Biosciences Inc. (SGMT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 191.49M |
| Enterprise Value | 156.54M |
| P/E Ratio | -5.67 |
| PEG Ratio | -0.22 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.43 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.4 |
| Return On Equity | -0.38 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -51.04M |
| Net Income | -51.04M |
| Diluted EPS | -1.58 |
| Total Cash | 104.54M |
| Total Cash/Share | 3.21 |
| Total Debt | 39,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 20.34 |
| Book Value Per Share | 3.15 |
| 52-Week Change | -19.9 |
| 52-Week High | 11.41 |
| 52-Week Low | 4.5 |
| Moving Average 50 Days | 7.17 |
| Moving Average 200 Days | 6.59 |
| Average Volume | 1.91M |
| Shares Outstanding | 32.58M |
| % Held by Institutions | 41.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |